Life Science Company News
Results 381 - 400 out of 500 displayed.
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
Strong momentum in Phase 3 trial; enrollment ahead of schedule;Expects to complete enrollment in the second quarter of 2023, just over one year from trial initiation;Anticipates topline data in the fourth quarter of 2023 Read more ››
By: PR Newswire Association LLC.
- 29 Mar 2023
By: PR Newswire Association LLC.
- 29 Mar 2023
Results 381 - 400 out of 500 displayed.
Enhance your business development with Biotechgate